Literature DB >> 10674025

Biological consequences of the BCR/ABL fusion gene in humans and mice.

M Y Gordon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10674025      PMCID： PMC501561          DOI： 10.1136/jcp.52.10.719

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  42 in total

1.  Quantitative measurements on the haemopoietic systems of three strains of mice.

Authors:  J E Coggle; M Y Gordon
Journal:  Exp Hematol       Date:  1975-06       Impact factor: 3.084

2.  Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV.

Authors:  C M Verfaillie; J B McCarthy; P B McGlave
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

3.  Autografting for patients with chronic myeloid leukaemia in chronic phase: peripheral blood stem cells may have a finite capacity for maintaining haemopoiesis.

Authors:  F Brito-Babapulle; S J Bowcock; R E Marcus; J Apperley; K H Th'ng; C Dowding; F Rassool; A P Guo; D Catovsky; D A Galton
Journal:  Br J Haematol       Date:  1989-09       Impact factor: 6.998

4.  A bcr-v-abl oncogene induces lymphomas in transgenic mice.

Authors:  I K Hariharan; A W Harris; M Crawford; H Abud; E Webb; S Cory; J M Adams
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

5.  Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome.

Authors:  G Q Daley; R A Van Etten; D Baltimore
Journal:  Science       Date:  1990-02-16       Impact factor: 47.728

6.  Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

Authors:  M A Kelliher; J McLaughlin; O N Witte; N Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

7.  Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients.

Authors:  M Talpaz; H Kantarjian; R Kurzrock; J M Trujillo; J U Gutterman
Journal:  Ann Intern Med       Date:  1991-04-01       Impact factor: 25.391

Review 8.  Cell biology of CML cells.

Authors:  M Y Gordon; F Dazzi; S B Marley; J L Lewis; D Nguyen; F H Grand; R J Davidson; J M Goldman
Journal:  Leukemia       Date:  1999-04       Impact factor: 11.528

9.  Propagation of human blastic myeloid leukemias in the SCID mouse.

Authors:  C L Sawyers; M L Gishizky; S Quan; D W Golde; O N Witte
Journal:  Blood       Date:  1992-04-15       Impact factor: 22.113

10.  Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice.

Authors:  M L Gishizky; J Johnson-White; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205
View more
  5 in total

1.  Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells.

Authors:  Clara Guerzoni; Michela Bardini; Samanta A Mariani; Giovanna Ferrari-Amorotti; Paolo Neviani; Maria Luisa Panno; Ying Zhang; Robert Martinez; Danilo Perrotti; Bruno Calabretta
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

2.  hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis.

Authors:  Angela Iervolino; Giorgia Santilli; Rossana Trotta; Clara Guerzoni; Vincenzo Cesi; Anna Bergamaschi; Carlo Gambacorti-Passerini; Bruno Calabretta; Danilo Perrotti
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 3.  Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors.

Authors:  Bruno Calabretta; Paolo Salomoni
Journal:  Leuk Lymphoma       Date:  2011-01-21

Review 4.  Suppression of autophagy by BCR/ABL.

Authors:  Bruno Calabretta; Paolo Salomoni
Journal:  Front Biosci (Schol Ed)       Date:  2012-01-01

5.  Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.

Authors:  Cristian Bellodi; Maria Rosa Lidonnici; Ashley Hamilton; G Vignir Helgason; Angela Rachele Soliera; Mattia Ronchetti; Sara Galavotti; Kenneth W Young; Tommaso Selmi; Rinat Yacobi; Richard A Van Etten; Nick Donato; Ann Hunter; David Dinsdale; Elena Tirrò; Paolo Vigneri; Pierluigi Nicotera; Martin J Dyer; Tessa Holyoake; Paolo Salomoni; Bruno Calabretta
Journal:  J Clin Invest       Date:  2009-04-13       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.